HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

483.155

-13.603-2.74%

Number of Gainers:7

Number of Losers:23

Number of Flat:3

PE:- -

High:496.758

Open:496.758

Low:480.328

Close:496.758

Volume:115.32M

Turnover:2.61B

Market Cap:306.93B

Float Cap:273.30B

Loading ...

Riding on One-Off Licensing Income, Suzhou Zelgen's Hong Kong Listing Ambitions Face Scrutiny Amid First Post-IPO Semi-Annual Profit

Ascletis Pharma Joins Two Chinese Stock Connect Programs

MT Newswires Live

HBM Holdings Enters Shanghai-, Shenzhen-Hong Kong Stock Connects

MT Newswires Live

CStone Pharmaceuticals Joins Stock Connect Southbound Trading

MT Newswires Live

Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results

MT Newswires Live

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

THOMSON REUTERS

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Hong Kong Stock Market Flash | METIS TECHBIO-P (07666) Surges Over 15% in Morning Session, Leading the AI Drug Development Sector as AI4S Commercialization Picks Up Pace

ALEBUND-B Announced H Shares Inclusion in Stock Connect and Hang Seng Composite Index

HBM Holdings-B(02142) Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists

CStone Pharma Shares Added to Southbound Stock Connect Eligible List

HBM Holdings Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists from Sept. 7, 2026

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Kintor Pharma Completes 52-Week Human Safety Trial of Skin-Whitening Ingredient KT-939

Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing

Hong Kong Stock Connect Biotech Surges: Dual-Antibody Outperforms Keytruda, Sector Heats Up

KeyMed Bio-B Announces Departure of Non-Executive Director

Keymed Biosciences Files Board, Committee Member List with Disclosure Roles

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/BK1574/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":483.15506,"timestamp":1789114133774,"preClose":496.75812,"halted":0,"volume":115323363,"delay":0,"changeRate":-0.027384,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.603058,"latestTime":"09-11 16:00:00","open":496.75812,"high":496.75812,"low":480.32812,"amount":2611810568,"amplitude":0.033074,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":3.703217,"peRate":164.740195,"turnoverRate":0.004215,"increases":6,"decrements":25,"flats":1,"marketCap":306930068880,"floatMarketCap":273297591592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":496.75812,"amplitude":0.033074,"preClose":496.75812,"low":480.32812,"pbRate":"3.703217","latestPrice":483.15506,"volume":115323363,"delay":0,"open":496.75812,"prevYearClose":556.26263,"prevWeekClose":532.025,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":532.025,"twentyDayClose":518.327,"sixtyDayClose":434.471,"secType":"PLATE","market":"HK","turnoverRate":0.004215,"peRate":164.740195,"marketCap":306930068880,"floatMarketCap":273297591592,"timestamp":1789114133774,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":23,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142074973","title":"Riding on One-Off Licensing Income, Suzhou Zelgen's Hong Kong Listing Ambitions Face Scrutiny Amid First Post-IPO Semi-Annual Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1142074973","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142074973?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:28","pubTimestamp":1788766134,"startTime":"0","endTime":"0","summary":"Suzhou Zelgen Biopharmaceuticals Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange main board, marking its second attempt, with China International Capital Corporation...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","688266","BK0239","HEXmain","IPOS","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665474394","title":"Ascletis Pharma Joins Two Chinese Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665474394","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665474394?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:34","pubTimestamp":1788762852,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective Sept. 7.The inclusion allows mainland Chinese investors to trade the biotech company's Hong Kong-listed shares through the Stock Connect platform, according to a Monday Hong Kong bourse filing.Shares of the drugmaker rose over 2% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02823","BK1515","KWEB","82822","02822","02843","ASHS","XPP","KCAI","FLCH","YXI","BK1161","CHAU","CWEB","YINN","KBA","BK1574","YANG","FXP","82823","01672","ASHR","82843"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665941093","title":"HBM Holdings Enters Shanghai-, Shenzhen-Hong Kong Stock Connects","url":"https://stock-news.laohu8.com/highlight/detail?id=2665941093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665941093?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:29","pubTimestamp":1788762578,"startTime":"0","endTime":"0","summary":"HBM Holdings'  shares have been included as eligible stocks under the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, according to a Monday bourse filing with the Hong Kong bourse.Qualified investors in mainland China can now directly invest in the company's shares through these Stock Connect programs.Shares of the biopharmaceutical company fell 1% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FLCH","FXP","MUZ","BK1161","MIC","RAM","RAMZ","BK1583","02142","MUD","82822","02843","YANG","DRAM","DRAL","MUYY","82823","CHAU","YINN","KBA","BK1574","HBMX","ASHR","02823","DISK","XPP","02822","KCAI","KWEB","BK4588","DRMP","MULL","MUG","82843","YXI","CWEB","DRMY","ASHS","MUU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665943143","title":"CStone Pharmaceuticals Joins Stock Connect Southbound Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2665943143","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665943143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:11","pubTimestamp":1788761498,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (HKG:2616) said its Hong Kong-listed shares have been added to the eligible securities list for southbound trading under Stock Connect, effective Sept. 7, according to a same-day Hong Kong bourse filing.Shares of the biopharmaceutical company fell nearly 1% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASHS","FXP","YINN","02823","YXI","82823","BK1161","KBA","CHAU","82822","XPP","CWEB","FLCH","02843","02616","82843","YANG","BK1574","ASHR","KCAI","KWEB","02822"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992903","title":"Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992903","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992903?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:11","pubTimestamp":1788757872,"startTime":"0","endTime":"0","summary":"Kintor Pharmaceutical  has disclosed positive results from the long-term safety trial of its skin tone correcting treatment, KT-939, according to a Monday bourse filing.Preliminary data showed that KT-939 was safe and well-tolerated, and participants treated with it for about a year did not experience any adverse skin reactions, the company said.Kintor said it is now working to advance KT-939's registration application for approval by the National Medical Products Administration before launching it commercially.The company's shares are up 5.5% in midday trading on the HKEX.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09939","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155170383","title":"Medical Device Inspection Campaign Launched by Ningyang County Market Regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=1155170383","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155170383?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:41","pubTimestamp":1788756073,"startTime":"0","endTime":"0","summary":"On September 7, enforcement officers from the Market Supervision Administration of Ningyang County, Shandong Province, visited retail pharmacies within their jurisdiction to conduct a targeted...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","HART","BK1100","159883","MDEV","MEDX","RSPH","LGHT","LNGR","IEIH","09996","PTH","BK1574","BK1583","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191894169","title":"MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1191894169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191894169?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754720,"startTime":"0","endTime":"0","summary":"As a wave of interim earnings reports floods in from medical device companies, the sector's recovery trajectory has become increasingly clear, with a definitive upward inflection point now visible in...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","AGNG","02041","MEDX","09996","159883","BK4585","LNGR","IEIH","BK1100","BK4588","PTH","BK1583","VXUS","MDEV","GDOC","HART","RSPH","KCAI","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399806","title":"Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399806?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:15","pubTimestamp":1788754501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUABQ4B5D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1574","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109390642","title":"UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1109390642","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109390642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:50","pubTimestamp":1788745830,"startTime":"0","endTime":"0","summary":"UBS has released a research note suggesting that while market expectations for the Chinese biotech sector's first-half results were initially conservative—due to concerns over tighter domestic drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU0244354667.USD","BK1515","BK1500","LU0326950275.SGD","LU0348767384.USD","LU0502904849.HKD","BK4139","LU0348827113.USD","LU0348783233.USD","LU0540923850.HKD","LU0196878994.USD","LU0588546209.SGD","LU1720050803.USD","LU2097828474.EUR","01801","01877","09926","LU0348766576.USD","688235","06160","09969","BK0239","LU1770034418.SGD","LU1251922891.USD","BK1588","LU0348735423.USD","LU2476274308.USD","LU0228659784.USD","LU1303224171.USD","LU2097828805.USD","BK1587","LU1969619763.USD","LU0634319403.HKD","00013","BK1589","LU0463099449.HKD","LU1794554557.SGD","LU2328871848.SGD","BK4585","LU2097828631.EUR","LU1719994722.HKD","LU0307460666.USD","HK0000165453.HKD","ONC","LU0561508036.HKD","KURE","LU2242644610.SGD","IE00B543WZ88.USD","LU0828237510.HKD","LU1961090484.USD","BK1574","LU0417516902.SGD","LU2488822045.USD","LU2476274720.SGD","LU1188198961.HKD","IE00B5MMRT66.SGD","BK1583","LU0348825331.USD","BK4526","LU2097828557.USD","LU2399975544.HKD","03069","BK1161","BK4588","LU2097828714.EUR","LU0417516738.SGD","LU0455707207.USD","LU2778985437.USD","LU0417516571.SGD","IE00BPRC5H50.USD","06990","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125017479","title":"Hong Kong Stock Market Flash | METIS TECHBIO-P (07666) Surges Over 15% in Morning Session, Leading the AI Drug Development Sector as AI4S Commercialization Picks Up Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=1125017479","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125017479?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:48","pubTimestamp":1788745710,"startTime":"0","endTime":"0","summary":"Shares of METIS TECHBIO-P (07666) climbed more than 15% in the morning trading session, taking the lead among AI drug development concept stocks. As of the time of writing, the stock was up 12.81%,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","AGIX","01477","BK4585","CHAT","07666","BK4588","BK1161","QTOC","VTHR","BK1574","KCAI","ARTY","BK1191","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187807186","title":"ALEBUND-B Announced H Shares Inclusion in Stock Connect and Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1187807186","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187807186?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:00","pubTimestamp":1788742832,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) has announced that, in accordance with the relevant arrangements and adjustments for Stock Connect, its H shares have been included in the list of eligible securities for Stock...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","HSCI","BK1161","09939","FLHK","09637","159938","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135620236","title":"HBM Holdings-B(02142) Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists","url":"https://stock-news.laohu8.com/highlight/detail?id=1135620236","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135620236?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:20","pubTimestamp":1788740410,"startTime":"0","endTime":"0","summary":"HBM Holdings-B (02142) announced that, effective September 7, 2026, its shares have been added to the lists of eligible securities under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665136045","title":"CStone Pharma Shares Added to Southbound Stock Connect Eligible List","url":"https://stock-news.laohu8.com/highlight/detail?id=2665136045","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665136045?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:06","pubTimestamp":1788739619,"startTime":"0","endTime":"0","summary":"CStone Pharma shares added to Southbound Stock Connect eligible listCStone Pharmaceuticals shares were added to the eligible securities list for southbound trading under Stock Connect, effective Sept.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL9DXY0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02616","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665115360","title":"HBM Holdings Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists from Sept. 7, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665115360","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665115360?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:00","pubTimestamp":1788739248,"startTime":"0","endTime":"0","summary":"HBM Holdings shares added to Shanghai and Shenzhen-Hong Kong Stock Connect lists from Sept. 7, 2026HBM Holdings shares will be added to the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stoc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDLccfMPv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184969761","title":"AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1184969761","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184969761?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:02","pubTimestamp":1788735760,"startTime":"0","endTime":"0","summary":"The innovative medicine sector is gaining significant momentum as artificial intelligence transforms the drug development landscape from discovery through clinical trials and regulatory approval. A...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1191","BK4588","VTHR","VXUS","BK1515","KCAI","BK1574","BK1617","MEDX","02228","06978","159992","CHAT","BK1141","AIPO","IBBQ","BK1593","QTOC","BK1161","AGIX","ARTY","02196","BK4585","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665438367","title":"Kintor Pharma Completes 52-Week Human Safety Trial of Skin-Whitening Ingredient KT-939","url":"https://stock-news.laohu8.com/highlight/detail?id=2665438367","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665438367?lang=en_us&edition=fundamental","pubTime":"2026-09-07 06:08","pubTimestamp":1788732492,"startTime":"0","endTime":"0","summary":"Kintor Pharma completes 52-week human safety trial of skin-whitening ingredient KT-939Kintor Pharmaceutical completed a 52-week long-term human safety trial of KT-939 on Sept. 4, 2026.Preliminary resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nNDL4qRNq1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167267027","title":"Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=1167267027","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167267027?lang=en_us&edition=fundamental","pubTime":"2026-09-06 20:40","pubTimestamp":1788698452,"startTime":"0","endTime":"0","summary":"On September 6, Sichuan Biokin Pharmaceutical Co., Ltd. (688506) issued a notice confirming its participation in the Star Market’s collective earnings briefing for the innovation drug sector covering...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LNGR","MEDX","688506","BK0239","BK1161","06978","159992","KSTR","IBBQ","91194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129584734","title":"Hong Kong Stock Connect Biotech Surges: Dual-Antibody Outperforms Keytruda, Sector Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1129584734","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129584734?lang=en_us&edition=fundamental","pubTime":"2026-09-06 19:22","pubTimestamp":1788693744,"startTime":"0","endTime":"0","summary":"The Hong Kong Stock Connect innovative drug sector finally sprung to life on September 4, posting its third consecutive session of gains with rising volume. The HUABAO HANG SENG HONG KONG STOCK...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","KURE","BK1574","LU0348784397.USD","LU2488822045.USD","LU0348767384.USD","520880","LU2778985437.USD","LU0348827113.USD","LU0540923850.HKD","LU2399975544.HKD","LU2476274308.USD","LU0348825331.USD","LU2476274720.SGD","BK1161","LU0417516571.SGD","09926","LU0561508036.HKD","IE00B543WZ88.USD","LU0348783233.USD","LU0417516902.SGD","LU0634319403.HKD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU1961090484.USD","IE00BPRC5H50.USD","LU0348766576.USD","LU1794554557.SGD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187916966","title":"KeyMed Bio-B Announces Departure of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1187916966","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187916966?lang=en_us&edition=fundamental","pubTime":"2026-09-06 18:44","pubTimestamp":1788691467,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) has officially announced that Dr. Wang Minchuan has tendered his resignation as a non-executive director of the company.The resignation will take effect from September 4, 2026, as stated in the company's recent filing.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","02162","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364508","title":"Keymed Biosciences Files Board, Committee Member List with Disclosure Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364508","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364508?lang=en_us&edition=fundamental","pubTime":"2026-09-06 18:32","pubTimestamp":1788690740,"startTime":"0","endTime":"0","summary":"Keymed Biosciences files board, committee member list with disclosure rolesKeymed Biosciences set its board lineup, dated Sept. 6, 2026, with three executive directors, two non-executive directors.Thr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nNDLcbVvQ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","BK1574","BK1583","02162"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":5,"totalSize":260,"code":"91000000","status":"200"}]}}